Search

Your search keyword '"Deanfield, John"' showing total 1,785 results

Search Constraints

Start Over You searched for: Author "Deanfield, John" Remove constraint Author: "Deanfield, John"
1,785 results on '"Deanfield, John"'

Search Results

2. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

3. The Effect of Semaglutide on Mortality and COVID-19–Related Deaths: An Analysis From the SELECT Trial

4. Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials

5. Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study

6. Socioeconomic representativeness of Australian, Canadian and British cohorts from the paediatric diabetes AdDIT study: comparisons to regional and national data

9. Deep-Learning for Epicardial Adipose Tissue Assessment With Computed Tomography: Implications for Cardiovascular Risk Prediction

10. Systems Analysis Implicates WAVE2 Complex in the Pathogenesis of Developmental Left-Sided Obstructive Heart Defects.

11. A national initiative in data science for health: an evaluation of the UK Farr Institute

12. Metabolomic profiles predict individual multidisease outcomes

13. Functional proteomic profiling links deficient DNA clearance with increased mortality in individuals with severe COVID-19 pneumonia

14. Constructing custom-made radiotranscriptomic signatures of vascular inflammation from routine CT angiograms: a prospective outcomes validation study in COVID-19

15. Sex-specific evaluation and redevelopment of the GRACE score in non-ST-segment elevation acute coronary syndromes in populations from the UK and Switzerland: a multinational analysis with external cohort validation

19. Urinary albumin/creatinine ratio tertiles predict risk of diabetic retinopathy progression: a natural history study from the Adolescent Cardio-Renal Intervention Trial (AdDIT) observational cohort

20. Neural network-based integration of polygenic and clinical information: development and validation of a prediction model for 10-year risk of major adverse cardiac events in the UK Biobank cohort

22. 45 The impact of cancer on bleeding risk among patients beyond 1 year post-myocardial infarction: an analysis of the virtual cardio-oncology research initiative (VICORI) database

23. Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial

24. Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial

25. #2496 Effect of semaglutide on kidney outcomes in people with overweight or obesity and established cardiovascular disease in the SELECT trial

26. Inflammatory risk and cardiovascular events in patients without obstructive coronary artery disease: the ORFAN multicentre, longitudinal cohort study

27. A predictive atlas of disease onset from retinal fundus photographs

28. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

30. Contribution of rare inherited and de novo variants in 2,871 congenital heart disease probands

33. Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT.

34. Effect of Semaglutide on Regression and Progression of Glycemia in People With Overweight or Obesity but Without Diabetes in the SELECT Trial.

35. A nationwide, population‐based study on specialized care for acute heart failure throughout the COVID‐19 pandemic.

36. Use of Static Cutoffs of Hypertension to Determine High cIMT in Children and Adolescents: An International Collaboration Study

38. De novo mutations in congenital heart disease with neurodevelopmental and other congenital anomalies

39. Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial

40. Medical history predicts phenome-wide disease onset and enables the rapid response to emerging health threats.

42. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

43. Dapagliflozin in Myocardial Infarction without Diabetes or Heart Failure

45. Semaglutide, inflammatory markers and cardiovascular outcomes in patients with overweight or obesity in the select trial

47. Work stress and risk of death in men and women with and without cardiometabolic disease: a multicohort study

49. The Adolescent Cardio-Renal Intervention Trial (AdDIT): retinal vascular geometry and renal function in adolescents with type 1 diabetes

50. De novo mutations in histone-modifying genes in congenital heart disease.

Catalog

Books, media, physical & digital resources